| scholarly article | Q13442814 |
| P356 | DOI | 10.2165/00044011-200828080-00006 |
| P698 | PubMed publication ID | 18598097 |
| P2093 | author name string | Lieven Annemans | |
| Hilde Van Campenhout | |||
| Marie-Paule Derde | |||
| Sophie Marbaix | |||
| P2860 | cites work | Why we need observational studies to evaluate the effectiveness of health care | Q24655465 |
| Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis | Q28217179 | ||
| Aspergillosis case-fatality rate: systematic review of the literature | Q31918085 | ||
| Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. | Q34455633 | ||
| Voriconazole: in the treatment of invasive aspergillosis | Q35016972 | ||
| Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001. | Q35219729 | ||
| Voriconazole: therapeutic review of a new azole antifungal | Q35917452 | ||
| The place for itraconazole in treatment | Q36239981 | ||
| Advances and challenges in management of invasive mycoses | Q36259905 | ||
| Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole | Q36511881 | ||
| Voriconazole : a review of its use in the management of invasive fungal infections | Q36729599 | ||
| Fungicidal versus Fungistatic: what's in a word? | Q37123394 | ||
| What observational studies can offer decision makers | Q38910831 | ||
| Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis | Q43864353 | ||
| Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation. | Q44245132 | ||
| Successful treatment with voriconazole of cerebral aspergillosis in an hematologic patient | Q44371948 | ||
| Economic evaluation of voriconazole compared with conventional amphotericin B for the primary treatment of aspergillosis in immunocompromised patients | Q44908635 | ||
| Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases | Q45015455 | ||
| Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy | Q45172488 | ||
| Economic evaluation of voriconazole in the treatment of invasive aspergillosis in the Netherlands | Q46765392 | ||
| Economic evaluation of voriconazole versus conventional amphotericin B in the treatment of invasive aspergillosis in Germany. | Q46915139 | ||
| Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies. | Q52024329 | ||
| Invasive aspergillosis | Q74492548 | ||
| Fungal infections | Q82626050 | ||
| P433 | issue | 8 | |
| P921 | main subject | aspergillosis | Q259626 |
| voriconazole | Q412236 | ||
| invasive aspergillosis | Q3625278 | ||
| P304 | page(s) | 509-521 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Clinical Drug Investigation | Q15753215 |
| P1476 | title | Voriconazole treatment of invasive aspergillosis: real-world versus health-economic model results | |
| P478 | volume | 28 |
| Q35942379 | An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole |
| Q34932560 | Attributable hospital cost and antifungal treatment of invasive fungal diseases in high-risk hematology patients: an economic modeling approach |
| Q37480190 | Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species |
| Q37936259 | Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studies |
| Q43226497 | Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Belgium |
| Q28752041 | Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus |
| Q38073334 | Pharmacoeconomic assessment of therapy for invasive aspergillosis |
| Q37702237 | Pharmacoeconomics of voriconazole |
| Q37820674 | Pharmacoeconomics of voriconazole in the management of invasive fungal infections |
| Q42861955 | Pulmonary Aspergillosis in a Non-Neutropenic Critical Patient |
Search more.